Abstract:A Simple Binary Supramolecular Co‐assembly Platform: A simple GSH‐responsive binary co‐assembly drug delivery platform to increase the concentration and exposure time of NR/Ce6 within tumor cells, thereby improving tumor imaging and therapeutic efficacy is developed. This simple and highly efficient platform can be adapted to a broad spectrum of probes and drugs, providing a new approach to advancing clinical diagnosis and therapy. The primary challenges in tumor imaging and therapy revolve around improving targeting efficiency, enhancing probe/drug delivery efficacy, and minimizing off‐target signals and toxicity. Although various carriers have been developed, many are difficult to synthesize, costly, and not universally applicable. Furthermore, numerous carriers exhibit limited delivery rates in solid tumors, particularly larger nanocarriers. To address these challenges, a simple binary co‐assembly drug delivery platform has been designed using the readily synthesized small molecule Cys(SEt)‐Lys‐CBT (CKCBT) as the self‐assembly building block. CKCBT can effectively penetrate tumor cells due to its positively charged Lys side chain and small size. Upon glutathione reduction, CKCBT co‐assembles with Nile red or Chlorin e6 to form nanofibers inside tumor cells. This enables their specific accumulation in tumor cells rather than normal cells and extends their exposure time, resulting in precise and enhanced tumor imaging and treatment. Hence, this uncomplicated and highly efficient binary co‐assembly drug delivery platform can be easily adapted to a broad spectrum of probes and drugs, presenting a novel approach for advancing clinical diagnosis and therapy.

Dual Engineering Interface-Driven Complementary Graphene Oxide-Protein Dimer Supramolecular Architecture Enables Nucleus Imaging and Therapy

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Receptor-targeting Fluorescence Imaging and Theranostics Using a Graphene Oxide Based Supramolecular Glycocomposite

Amphiphilic Graphene Quantum Dots As Self‐Targeted Fluorescence Probes for Cell Nucleus Imaging

Graphene-Based Magnetic Plasmonic Nanocomposite for Dual Bioimaging and Photothermal Therapy

Engineering Molecular Self-Assembly of Theranostic Nanoprobes for Dual-Modal Imaging-Guided Precise Chemotherapy

Biomimetic Smart Nanoplatform for Dual Imaging-Guided Synergistic Cancer Therapy.

Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy

Graphene-Oxide-Modified Lanthanide Nanoprobes for Tumor-Targeted Visible/NIR-II Luminescence Imaging

Synergistic Targeting and Efficient Photodynamic Therapy Based on Graphene Oxide Quantum Dot-Upconversion Nanocrystal Hybrid Nanoparticles

Clickable amino acid tuned self-assembly of a nucleus-selective multi-component nanoplatform for synergistic cancer therapy

Multifunctional Graphene Oxide‐based Triple Stimuli‐Responsive Nanotheranostics

Eco-Friendly Development Of An Ultrasmall Ionp-Loaded Nanoplatform For Bimodal Imaging-Guided Cancer Theranostics

Simultaneous nuclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes.

Biofunctionalized graphene oxide nanosheet for amplifying antitumor therapy: Multimodal high drug encapsulation, prolonged hyperthermal window, and deep-site burst drug release

A Simple Binary Supramolecular Co‐Assembly Platform for Enhanced Tumor Imaging and Therapy

A C5N2 Nanoparticles-Based Direct Nucleus Delivery Platform for Synergistic Cancer Therapy.

Supramolecularly Engineered NIR‐II and Upconversion Nanoparticles in Vivo Assembly and Disassembly to Improve Bioimaging

Graphene oxide-templated biomineralization nanosystem enables multi-drug loading and controllable release

Biomimetic light-activatable graphene-based nanoarchitecture for synergistic chemophotothermal therapy

Cobalt Nanowire-Based Multifunctional Platform for Targeted Chemo-Photothermal Synergistic Cancer Therapy.